Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: BABA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on BABA, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 35,161 BABA shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 35,161 shares
    Change vs previous 13F -47 shares

    0.06% of the 13F portfolio, value $3,374,753.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 35,208 shares
    Change vs previous 13F -3,309 shares

    0.09% of the 13F portfolio, value $4,417,196.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 38,517 shares
    Change vs previous 13F -5,022 shares

    0.12% of the 13F portfolio, value $5,646,245.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 43,539 shares
    Change vs previous 13F -83 shares

    0.17% of the 13F portfolio, value $7,782,313.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 43,622 shares
    Change vs previous 13F 0 shares

    0.15% of the 13F portfolio, value $4,947,548.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 43,622 shares
    Change vs previous 13F -186,191 shares

    0.18% of the 13F portfolio, value $5,768,600.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 229,813 shares
    Change vs previous 13F -145,614 shares

    0.68% of the 13F portfolio, value $19,487,418.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 375,427 shares
    Change vs previous 13F not available

    1.38% of the 13F portfolio, value $39,843,185.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).